TAS0728, A Covalent-binding, HER2-selective Kinase Inhibitor Shows Potent Antitumor Activity in Preclinical Models (Q91761025)
Jump to navigation
Jump to search
scientific article published on 20 February 2019
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | TAS0728, A Covalent-binding, HER2-selective Kinase Inhibitor Shows Potent Antitumor Activity in Preclinical Models |
scientific article published on 20 February 2019 |
Statements
TAS0728, A Covalent-binding, HER2-selective Kinase Inhibitor Shows Potent Antitumor Activity in Preclinical Models (English)
Hiroki Irie
Kimihiro Ito
Yayoi Fujioka
Kei Oguchi
Akio Fujioka
Akihiro Hashimoto
Hirokazu Ohsawa
Kenji Tanaka
Kaoru Funabashi
Hikari Araki
Yuichi Kawai
Tadashi Shimamura
Renu Wadhwa